{"ok":true,"trend":{"id":419585,"platform":"google","region":"BR","key":"retatrutide","title":"retatrutide","url":"https://trends.google.com/trending?geo=BR&q=retatrutide","first_seen":"2026-09-30T00:20:46.772399Z","last_seen":"2026-09-30T02:05:47.190219Z","last_rank":7,"peak_rank":1,"last_volume":2000,"peak_volume":2000,"seen_count":8,"score":0.65484375,"category_hint":null,"section":null,"category":null,"summary":"Retatrutide, an experimental obesity drug from Eli Lilly, is drawing major attention after trial results showed participants losing up to 25% of their body weight, reportedly making it the most powerful obesity drug tested so far. The findings are fueling discussion about the next generation of weight-loss treatments beyond semaglutide and tirzepatide, with strong interest in the US, UK and Brazil.","why":"New trial results showing record weight loss with retatrutide have just been widely reported.","tone":"positive","entities":["Retatrutide","Eli Lilly"],"summarized_at":"2026-09-30T00:22:29.076924Z","meta":{"lang":"en","picture":"https://encrypted-tbn3.gstatic.com/images?q=tbn:ANd9GcSrPNt_8_Ac-mU3zIiRrTBIRfP5JflYy-tupix7R3c-d22jrIbztMRWc9eLD-Q","traffic":"2000+","published":"Tue, 29 Sep 2026 17:00:00 -0700","picture_source":"The Guardian"},"nw":null,"promo":null,"kind":null,"importance":null,"hidden":false,"hide_reason":null,"judged_at":null,"title_en":"Retatrutide weight-loss trial shows up to 25% body weight reduction","timeline":[{"captured_at":"2026-09-30T00:20:46.772399Z","rank":1,"volume":1000},{"captured_at":"2026-09-30T00:35:46.489805Z","rank":1,"volume":1000},{"captured_at":"2026-09-30T00:50:49.066786Z","rank":3,"volume":2000},{"captured_at":"2026-09-30T01:05:45.355989Z","rank":4,"volume":2000},{"captured_at":"2026-09-30T01:20:48.596489Z","rank":5,"volume":2000},{"captured_at":"2026-09-30T01:35:47.908747Z","rank":5,"volume":2000},{"captured_at":"2026-09-30T01:50:47.499708Z","rank":7,"volume":2000},{"captured_at":"2026-09-30T02:05:47.190219Z","rank":7,"volume":2000}],"posts":[{"platform":"google","url":"https://www.nbcnews.com/health/health-news/retatrutide-type-2-diabetes-lilly-weight-loss-drug-rcna600536","author":"NBC News","title":"People with Type 2 diabetes lost up to 60 pounds on Lilly’s latest weight loss drug","snippet":null,"posted_at":null,"likes":null},{"platform":"google","url":"https://www.reuters.com/business/healthcare-pharmaceuticals/lillys-experimental-drug-cuts-weight-by-21-diabetes-trial-2026-09-29/","author":"Reuters","title":"Lilly's experimental drug cuts weight by 21% in diabetes trial","snippet":null,"posted_at":null,"likes":null},{"platform":"google","url":"https://arstechnica.com/health/2026/09/most-powerful-obesity-drug-yet-people-lost-up-to-25-of-weight-in-trial/","author":"Ars Technica","title":"Most powerful obesity drug yet: People lost up to 25% of weight in trial","snippet":null,"posted_at":null,"likes":null}],"elsewhere":[{"id":416929,"platform":"google","region":"GB","title":"retatrutide","last_rank":10,"last_seen":"2026-09-30T04:35:46.961762Z","summary":"Eli Lilly's experimental drug retatrutide is drawing global attention after new trial results showed people lost up to 25% of their body weight, with patients who have Type 2 diabetes shedding as much as 60 pounds, or roughly 21% of their weight. Outlets including Reuters, NBC News and Ars Technica describe it as potentially the most powerful obesity drug yet, and searches are spiking in the US, UK and Brazil."},{"id":415637,"platform":"google","region":"US","title":"retatrutide","last_rank":10,"last_seen":"2026-09-29T23:50:48.233054Z","summary":"Retatrutide, an experimental obesity drug from Eli Lilly, is drawing attention after trial results showed participants losing up to 25% of their body weight, making it potentially the most powerful obesity drug tested to date. Coverage, including Ars Technica's report on the findings, is fueling discussion about how it might compare to established treatments like tirzepatide and semaglutide."}],"window":"7d"}}